Related Experiment Video

Updated: Jun 8, 2026

A Surgical Procedure for the Administration of Drugs to the Inner Ear in a Non-Human Primate Common Marmoset (Callithrix jacchus)
06:55

A Surgical Procedure for the Administration of Drugs to the Inner Ear in a Non-Human Primate Common Marmoset (Callithrix jacchus)

Published on: February 27, 2018

[Treatment of pneumococcal meningitis with dexamethasone]

A Felipe Rucián1, G García Del Cerro, F Coll Usandizaga

  • 1Servicio de Pediatría, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona, Barcelona, Spain.

Anales De Pediatria (Barcelona, Spain : 2003)
|October 5, 2010
PubMed

Insights

Comparing short (48h) versus long (96h) dexamethasone courses for pneumococcal meningitis showed no significant differences in outcomes, despite a longer fever duration with shorter treatment.

Area of Science:

  • Infectious Diseases
  • Neurology
  • Pharmacology

Background:

  • Pneumococcal meningitis is a serious infection requiring prompt treatment.
  • Dexamethasone is commonly used as an adjunctive therapy to reduce inflammation and neurological sequelae.
  • Optimal dexamethasone administration schedule remains under investigation.

Purpose of the Study:

  • To compare the efficacy of a short-course (48-hour) versus a long-course (96-hour) dexamethasone administration in patients with pneumococcal meningitis.
  • To evaluate the impact of different dexamethasone durations on primary and secondary fever, neurological handicaps, and mortality.

Main Methods:

  • A comparative study involving 18 patients diagnosed with pneumococcal meningitis.
  • Patients were treated with either a 48-hour or a 96-hour course of dexamethasone.
  • Outcomes assessed included duration of primary fever, incidence of secondary fever, severe neurological handicaps, and mortality.

Main Results:

  • A statistically significant longer duration of primary fever was observed in the group receiving a 48-hour dexamethasone course.
  • No significant differences were found between the two groups regarding secondary fever, severe neurological handicaps, or mortality.
  • The study identified no significant differences in overall patient outcomes between the short and long dexamethasone treatment schedules.

Conclusions:

  • Both short-course (48h) and long-course (96h) dexamethasone administration appear to be similarly effective in managing pneumococcal meningitis.
  • Further research is needed to identify early prognostic markers for improved patient outcomes.
  • Development of novel adjuvant therapies is crucial for enhancing recovery and reducing long-term complications in pneumococcal meningitis patients.

More Related Videos

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma08:00

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...